[Left main percutaneous coronary intervention using zotarolimus-eluting stent: data from the ROLEX registry]

G Ital Cardiol (Rome). 2022 Dec;23(12 Suppl 2):36S-37S. doi: 10.1714/3949.39291.
[Article in Italian]
No abstract available

MeSH terms

  • Coronary Artery Disease*
  • Drug-Eluting Stents*
  • Humans
  • Percutaneous Coronary Intervention*
  • Prosthesis Design
  • Registries
  • Sirolimus
  • Treatment Outcome

Substances

  • zotarolimus
  • Sirolimus